EQUASHIELD, a pioneer in closed system transfer devices (CSTDs) and automated pharmacy compounding solutions, is thrilled to announce its remarkable achievement of being named by the Pharmacy Purchasing & Products as the most used device in the preparation and administration of hazardous drugs for five consecutive years.
Following convincing results from a recent In-Vitro study, the Danish biotech company, Tetra Pharm Technologies, announces successful In-Vivo study results of its candidate compound, TPT0301.
Alliance for Multispecialty Research (AMR), a leading integrated research site organization, announced the appointment of Kari L. Delahunty as the Company's first Chief Operating Officer. An experienced leader, Delahunty will help support the growth and expansion of AMR's award-winning clinical research site network in new and existing markets across the U.S.
CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and organ manufacturing, announced financial results for the second quarter ended June 30, 2023, and provided a corporate update on its programs.
GSK plc (LSE/NYSE: GSK) announced that AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) is now available in the US at all major retail pharmacies.
Wheeler Bio, Inc., an agile, boutique, clinical contract development and manufacturing organization (CDMO) announced the appointment of Marc Helouin as Chief Quality and Regulatory Officer (CQRO).
Bridge to Life Ltd., a leading global supplier of organ preservation and perfusion technologies, announced results from interim analysis of its multicenter, randomized, controlled liver clinical trial presented at the 2023 American Transplant Congress (ATC).
Young Pharmaceuticals, Inc., a leading provider of physician-dispensed skincare, announces an exclusive distribution agreement with Boulder-based TrulyO2, a maker of proprietary topical micro-oxygen delivery products.
RedShift BioAnalytics (RedShiftBio®) announces the launch of Aurora, the company's latest system using ground-breaking MMS technology.
Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving nearly 38 million members nationally, announced that Mostafa Kamal will succeed Ken Paulus as President and CEO of Prime Therapeutics.